AbCellera Biologics (ABCL) Shares Outstanding (Weighted Average): 2020-2025
Historic Shares Outstanding (Weighted Average) for AbCellera Biologics (ABCL) over the last 6 years, with Sep 2025 value amounting to $298.8 million.
- AbCellera Biologics' Shares Outstanding (Weighted Average) rose 1.41% to $298.8 million in Q3 2025 from the same period last year, while for Sep 2023 it was $289.4 million, marking a year-over-year increase of 1.48%. This contributed to the annual value of $295.4 million for FY2024, which is 1.79% up from last year.
- Per AbCellera Biologics' latest filing, its Shares Outstanding (Weighted Average) stood at $298.8 million for Q3 2025, which was up 0.12% from $298.5 million recorded in Q2 2025.
- AbCellera Biologics' 5-year Shares Outstanding (Weighted Average) high stood at $298.8 million for Q3 2025, and its period low was $269.5 million during Q1 2021.
- For the 3-year period, AbCellera Biologics' Shares Outstanding (Weighted Average) averaged around $293.5 million, with its median value being $294.1 million (2024).
- Data for AbCellera Biologics' Shares Outstanding (Weighted Average) shows a peak YoY climbed of 5.88% (in 2021) over the last 5 years.
- Over the past 5 years, AbCellera Biologics' Shares Outstanding (Weighted Average) (Quarterly) stood at $281.6 million in 2021, then rose by 1.60% to $286.1 million in 2022, then rose by 1.42% to $290.2 million in 2023, then increased by 1.79% to $295.4 million in 2024, then increased by 1.41% to $298.8 million in 2025.
- Its last three reported values are $298.8 million in Q3 2025, $298.5 million for Q2 2025, and $298.0 million during Q1 2025.